Literature DB >> 11292026

The role of STAT6 in mast cell IL-4 production.

M A Sherman1.   

Abstract

Interleukin (IL)-4 has an important role in regulating antibody production and inflammation. The major IL-4 producers are CD4+ T cells, but the development of an IL-4-producing phenotype in these cells requires IL-4 signaling through the STAT6 pathway during differentiation. The cellular source of this early IL-4 is not known, but mast cells are a possible candidate due to their immediate and indiscriminate release of IL-4 upon activation. In this review we summarize the evidence that STAT6 signaling is not required for mast cell IL-4 production, which is consistent with their possible role as a link between the innate immune response and T-cell activation. We also describe an isoform of STAT6 that is expressed in mast cells and that appears to act as a repressor of IL-4 transcription. This STAT6 signaling pathway may be part of a feedback mechanism to protect surrounding tissues from IL-4-mediated inflammation during an infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292026     DOI: 10.1034/j.1600-065x.2001.790105.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  9 in total

1.  Non-FcεR bearing mast cells secrete sufficient interleukin-4 to control Francisella tularensis replication within macrophages.

Authors:  Prea Thathiah; Shilpa Sanapala; Annette R Rodriguez; Jieh-Juen Yu; Ashlesh K Murthy; M Neal Guentzel; Thomas G Forsthuber; James P Chambers; Bernard P Arulanandam
Journal:  Cytokine       Date:  2011-05-12       Impact factor: 3.861

2.  Sodium Benzoate, a Food Additive and a Metabolite of Cinnamon, Enriches Regulatory T Cells via STAT6-Mediated Upregulation of TGF-β.

Authors:  Madhuchhanda Kundu; Susanta Mondal; Avik Roy; Jeffrey L Martinson; Kalipada Pahan
Journal:  J Immunol       Date:  2016-09-07       Impact factor: 5.422

3.  Selective inhibition by rottlerin of macropinocytosis in monocyte-derived dendritic cells.

Authors:  Kakali Sarkar; Michael J Kruhlak; Stanley L Erlandsen; Stephen Shaw
Journal:  Immunology       Date:  2005-12       Impact factor: 7.397

4.  Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling.

Authors:  Laimute Taraseviciene-Stewart; Mark R Nicolls; Donatas Kraskauskas; Robertas Scerbavicius; Nana Burns; Carlyne Cool; Kathy Wood; Jane E Parr; Susan A Boackle; Norbert F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  2007-04-05       Impact factor: 21.405

Review 5.  Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges.

Authors:  Bocheng Wu; Quaovi H Sodji; Adegboyega K Oyelere
Journal:  Cancers (Basel)       Date:  2022-01-22       Impact factor: 6.639

Review 6.  Transcription Factors in the Development and Pro-Allergic Function of Mast Cells.

Authors:  Mansi Srivastava; Mark H Kaplan
Journal:  Front Allergy       Date:  2021-06-07

Review 7.  Targeting Mast Cells in Allergic Disease: Current Therapies and Drug Repurposing.

Authors:  Jason R Burchett; Jordan M Dailey; Sydney A Kee; Destiny T Pryor; Aditya Kotha; Roma A Kankaria; David B Straus; John J Ryan
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

8.  Proteolytic processing of Stat6 signaling in mast cells as a negative regulatory mechanism.

Authors:  Kotaro Suzuki; Hiroshi Nakajima; Shin-Ichiro Kagami; Akira Suto; Kei Ikeda; Koichi Hirose; Takaki Hiwasa; Kiyoshi Takeda; Yasushi Saito; Shizuo Akira; Itsuo Iwamoto
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

9.  The gene expression level of IFN-γR1 and IFN-γR2 in a murine model treated with Toxoplasma gondii and its products.

Authors:  Hamed Kalani; Hosein Khanahmad Shahreza; Ahmad Daryani; Hosein Ali Yousefi; Nader Pestechian; Vahid Mansouri
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.